Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Tyra Biosciences Raises $50 Million In Cancer Fight

Co. Targets Cancers That Have Become Drug Resistant

Device Companies See Advantage In Partnering With Big Tech

From Hardware to Data, Verily Helping Local Companies Better Cater to Consumer Needs

Tease photo

ResMed Settles Kickback Allegations, Agrees to Pay $37.5M

ResMed will pay $37.5 million to settle allegations that the company paid kickbacks to suppliers, sleep labs and other health care providers, the Department of Justice recently announced.

Biotech Awarded up to $9M to Develop Coronavirus Vaccine

Inovio Pharmaceuticals was recently awarded up to a $9 million grant to develop a vaccine against a strain of coronavirus that’s spreading in China and spurred screening at U.S. airports.

Actor Gets Role at Scripps Bridging Communication Gap

Inovio Awarded $9M for Coronavirus Research

Tease photo

Tyra Biosciences Raises $50M to Take On Drug Resistant Cancers

Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has raised a $50 million round.

Cos. Find Deals, Dollars at J.P. Morgan

BIOTECH: HL Buys, Sells; New Partnership Unveiled for Illumina

Debut Looks to Move Drug Manufacturing Forward

San Diego-Based Co. Closes $2.6 Million Seed Round

Neurocrine Deal Potentially Worth $412 Million

Company Would Pay Idorsia If It Licenses Drug

San Diego Companies Find Deals and Dollars at Health Conference

Two DNA sequencing companies raised more than $140 million combined, Daré Bioscience inked a potential commercialization deal worth up to $310 million, and Human Longevity sold its cancer division for $37 million, and separately, acquired a company.

Tease photo

More stories >>